A healthy start to 2024; outlook re-iterated
17/04/24 -"Q1 sales exceeded expectations, driven by a strong performance from the Companion Animal segment. The Farm Animal segment was however held back by a ‘temporary’ decline in the ruminant offerings. The ..."
Pages
56
Language
English
Published on
17/04/24
You may also be interested by these reports :
30/04/24
Similar to other Smaller Pharmas, the family-controlled Ipsen’s (BUY; France) share price performance over the last two years has been disappointing ...
26/04/24
The Q1 profits surpassed the street’s expectations, as all the three key molecules witnessed decent growth. Segment-wise, Spain and International ...
26/04/24
Hikma’s qualitative Q1 commentary entailed a positive tone for all the segments. Moreover, the management reaffirmed the full-year guidance. Since ...
25/04/24
The Q1 results topped expectations, led by robust performances across all the key segments. While the management maintained its 2024 guidance, an ...